SonoScape Medical Corp (300633) — Working Capital to Net Assets Ratio
SonoScape Medical Corp (300633) has a Working Capital to Net Assets ratio of 54.8% as of March 2026. Working capital of CN¥1.79 Billion (current assets of CN¥2.70 Billion minus current liabilities of CN¥914.13 Million) is measured against net assets of CN¥3.26 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See SonoScape Medical Corp free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
SonoScape Medical Corp Working Capital to Net Assets (2012–2025)
This chart shows how SonoScape Medical Corp's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 54.8%, reflecting working capital of CN¥1.79 Billion against net assets of CN¥3.26 Billion CNY. See SonoScape Medical Corp liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for SonoScape Medical Corp (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for SonoScape Medical Corp from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of SonoScape Medical Corp.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 55.0% | CN¥1.80 Billion | CN¥3.26 Billion | CN¥2.82 Billion | CN¥1.02 Billion | ▼ -5.8 pp |
| 2024 | 60.9% | CN¥1.89 Billion | CN¥3.11 Billion | CN¥2.97 Billion | CN¥1.08 Billion | ▼ -4.5 pp |
| 2023 | 65.4% | CN¥2.06 Billion | CN¥3.15 Billion | CN¥2.63 Billion | CN¥568.62 Million | ▲ +1.0 pp |
| 2022 | 64.4% | CN¥1.76 Billion | CN¥2.74 Billion | CN¥2.51 Billion | CN¥749.42 Million | ▼ -2.5 pp |
| 2021 | 66.9% | CN¥1.58 Billion | CN¥2.36 Billion | CN¥2.13 Billion | CN¥555.83 Million | ▲ +17.6 pp |
| 2020 | 49.3% | CN¥663.33 Million | CN¥1.34 Billion | CN¥1.49 Billion | CN¥827.81 Million | ▼ -11.2 pp |
| 2019 | 60.5% | CN¥849.99 Million | CN¥1.40 Billion | CN¥1.54 Billion | CN¥693.80 Million | ▲ +8.9 pp |
| 2018 | 51.7% | CN¥677.45 Million | CN¥1.31 Billion | CN¥1.14 Billion | CN¥460.73 Million | ▼ -30.4 pp |
| 2017 | 82.0% | CN¥869.15 Million | CN¥1.06 Billion | CN¥1.09 Billion | CN¥218.96 Million | ▲ +5.5 pp |
| 2016 | 76.6% | CN¥551.50 Million | CN¥720.11 Million | CN¥791.10 Million | CN¥239.60 Million | ▼ -9.8 pp |
| 2015 | 86.4% | CN¥489.19 Million | CN¥566.21 Million | CN¥721.02 Million | CN¥231.82 Million | ▲ +3.1 pp |
| 2014 | 83.3% | CN¥370.58 Million | CN¥444.81 Million | CN¥656.87 Million | CN¥286.29 Million | ▲ +5.3 pp |
| 2013 | 78.0% | CN¥284.86 Million | CN¥365.08 Million | CN¥431.04 Million | CN¥146.19 Million | ▲ +21.3 pp |
| 2012 | 56.7% | CN¥199.41 Million | CN¥351.82 Million | CN¥416.06 Million | CN¥216.65 Million | — |